WuXi PharmaTech (Cayman) Inc. Proceeds from Stock Options Exercised
WuXi PharmaTech (Cayman) Inc. reported Proceeds from Stock Options Exercised of $2.23 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2015-04-15
| Period end | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 12 month as first filed |
|---|---|---|
| 2014-12-31 | $2.23M 20-F · filed 2015-04-15 | |
| 2013-12-31 | $4.95M 20-F · filed 2015-04-15 | $4.95M 20-F · filed 2014-04-15 |
| 2012-12-31 | $1.38M 20-F · filed 2015-04-15 | $1.38M 20-F · filed 2013-04-17 |
| 2011-12-31 | $1.64M 20-F · filed 2014-04-15 | |
| 2010-12-31 | $2.36M 20-F · filed 2013-04-17 | |
| 2009-12-31 | $1.42M 20-F · filed 2012-04-20 | |
| 2008-12-31 | $1.01M 20-F · filed 2011-04-27 |